Scientists test Anti-Aging cocktail for smokers
NCT ID NCT07058974
Summary
This early-stage study is testing whether a combination of exercise, a dietary supplement (spermidine), and one of two drugs (rapamycin or lamivudine) is safe and feasible for older adults who smoke or used to smoke. The main goal is to see if participants can stick to the regimen and to check for serious side effects. Researchers will also measure blood markers related to inflammation and aging to understand how these interventions might work together.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
RECRUITINGNew York, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.